AU3744800A - Controlled release of sildenafil delivered by sublingual or buccal administration - Google Patents

Controlled release of sildenafil delivered by sublingual or buccal administration

Info

Publication number
AU3744800A
AU3744800A AU37448/00A AU3744800A AU3744800A AU 3744800 A AU3744800 A AU 3744800A AU 37448/00 A AU37448/00 A AU 37448/00A AU 3744800 A AU3744800 A AU 3744800A AU 3744800 A AU3744800 A AU 3744800A
Authority
AU
Australia
Prior art keywords
sildenafil
sublingual
delivered
controlled release
buccal administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37448/00A
Inventor
Ragab El-Rashidy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pentech Pharmaceuticals Inc
Original Assignee
Pentech Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentech Pharmaceuticals Inc filed Critical Pentech Pharmaceuticals Inc
Publication of AU3744800A publication Critical patent/AU3744800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU37448/00A 1999-03-16 2000-03-14 Controlled release of sildenafil delivered by sublingual or buccal administration Abandoned AU3744800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26895799A 1999-03-16 1999-03-16
US09268957 1999-03-16
PCT/US2000/006662 WO2000054777A1 (en) 1999-03-16 2000-03-14 Controlled release of sildenafil delivered by sublingual or buccal administration

Publications (1)

Publication Number Publication Date
AU3744800A true AU3744800A (en) 2000-10-04

Family

ID=23025240

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37448/00A Abandoned AU3744800A (en) 1999-03-16 2000-03-14 Controlled release of sildenafil delivered by sublingual or buccal administration

Country Status (4)

Country Link
EP (1) EP1171134A4 (en)
JP (1) JP2002539165A (en)
AU (1) AU3744800A (en)
WO (1) WO2000054777A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT199900061A (en) * 1998-05-15 2000-10-14 Pfizer PHARMACEUTICAL FORMULATIONS.
DE10244504A1 (en) * 2002-09-25 2004-04-08 Capsulution Nanoscience Ag Quick-release dosage form with poorly soluble active ingredient
MX2008000087A (en) * 2005-06-23 2008-03-18 Schering Corp Rapidly absorbing oral formulations of pde5 inhibitors.
WO2007018057A1 (en) * 2005-08-05 2007-02-15 Freund Corporation Tablet rapidly disintegrating in the oral cavity and method of producing the same
KR101004205B1 (en) * 2008-12-17 2010-12-24 동아제약주식회사 The controlled released pharmaceutical compsitions of udenafil for sustained release property
DE102009016584A1 (en) * 2009-04-06 2010-10-07 Ratiopharm Gmbh Orodispersible tablet containing a sildenafil salt
WO2011019819A1 (en) * 2009-08-12 2011-02-17 Forest Laboratories Holdings Limited Orally disintegrating compositions of linaclotide
CN107880047A (en) * 2015-07-23 2018-04-06 青岛华之草医药科技有限公司 A kind of sildenafil citrate compound
SE544672C2 (en) * 2020-05-07 2022-10-11 Liw Innovation Ab New compositions for oral or nasal use
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250534A (en) * 1990-06-20 1993-10-05 Pfizer Inc. Pyrazolopyrimidinone antianginal agents
US5624677A (en) * 1995-06-13 1997-04-29 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
EP0992240A4 (en) * 1997-05-29 2003-04-16 Mochida Pharm Co Ltd Therapeutic agent for erection failure
GT199900061A (en) * 1998-05-15 2000-10-14 Pfizer PHARMACEUTICAL FORMULATIONS.

Also Published As

Publication number Publication date
EP1171134A4 (en) 2005-01-05
EP1171134A1 (en) 2002-01-16
JP2002539165A (en) 2002-11-19
WO2000054777A1 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
IL132646A0 (en) Controlled release of drugs delivered by sublingual or buccal administration
AU2276801A (en) Extended release oral dosage composition
AU3977099A (en) Controlled release oral dosage form
AU6089200A (en) Rapid immediate release oral dosage form
AU2115301A (en) Dental compositions
AU4847500A (en) Highly crystalline eaodm interpolymers
AU2277101A (en) Stable extended release oral dosage composition
AU2001239282A1 (en) Orthodontic bracket
AU2001289728A1 (en) Orthodontic bracket
AU2002363360A1 (en) Dual controlled release dosage form
AU1998200A (en) Multiparticulate oral dosage forms
AU2002229140A1 (en) Controlled release pharmaceutical composition
AU2002248377A1 (en) A controlled release pharmaceutical composition
AU2001279540A1 (en) Dental splint
AU1713501A (en) Bilayered buccal tablets comprising nicotine
AU3640399A (en) Respiratory aids
AU2001287977A1 (en) Controlled release formulations for oral administration
AU3120900A (en) Lingualize occlusal bur
AU4428000A (en) Pulse-delivery oral compositions
AU4107101A (en) Denture attachment
AU3744800A (en) Controlled release of sildenafil delivered by sublingual or buccal administration
AU2001248772A1 (en) Sustained release drug compositions
AU2003290436A1 (en) Oral preparation system
IL148908A0 (en) Oral controlled release formulations
AU1732401A (en) Medicinal compositions for oral use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase